公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Genetic analysis identifies the role of HLF in renal cell carcinoma | CHAO-YUAN HUANG ; HUANG S.-P.; HSUEH Y.-M.; CHEN L.-C.; LU T.-L.; BAO B.-Y. | Cancer Genomics and Proteomics | 6 | 6 | |
2020 | Genetic analysis reveals a significant contribution of ces1 to prostate cancer progression in taiwanese men | Ke C.-C.; Chen L.-C.; Yu C.-C.; Cheng W.-C.; CHAO-YUAN HUANG ; Lin V.C.; Lu T.-L.; Huang S.-P.; Bao B.-Y. | Cancers | 8 | 9 | |
2020 | Genetic association analysis identifies a role for ANO5 in prostate cancer progression | Yu C.-C.; Chen L.-C.; CHAO-YUAN HUANG ; Lin V.C.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. | Cancer Medicine | 10 | 9 | |
2020 | Genetic association analysis of cell cycle regulators reveals YWHAZ has prognostic significance in prostate cancer | Yu C.-C.; Chen L.-C.; Lin W.-H.; Lin V.C.; CHAO YUAN HUANG ; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. | Cancer Genomics and Proteomics | 8 | 7 | |
2012 | Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; YEONG-SHIAU PU ; Hsieh C.-J.; Bao B.-Y. | Annals of Oncology | 42 | 39 | |
2012 | Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; CHAO-YUAN HUANG ; Hsieh C.-J.; Bao B.-Y. | Journal of Internal Medicine | 32 | 31 | |
2021 | Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes | Tsai Y.-C.; CHAO-YUAN HUANG ; Hsueh Y.-M.; Fan Y.-C.; Fong Y.-C.; Huang S.-P.; Geng J.-H.; Chen L.-C.; Lu T.-L.; Bao B.-Y. | Life Sciences | 5 | 5 | |
2013 | Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients | Huang S.-P.; Lin V.C.; Lee Y.-C.; Yu C.-C.; CHAO-YUAN HUANG ; Chang T.-Y.; Lee H.-Z.; Juang S.-H.; Lu T.-L.; Bao B.-Y. | European Journal of Cancer | 19 | 20 | |
2019 | Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression | Yu C.-C.; Chen L.-C.; Chiou C.-Y.; Chang Y.-J.; Lin V.C.; CHAO-YUAN HUANG ; Lin I.-L.; Chang T.-Y.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. | Cancer Cell International | 15 | 13 | |
2016 | Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival | Bao B.-Y.; Lin V.C.; Yu C.-C.; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Lee H.-Z.; Pao J.-B.; CHAO-YUAN HUANG ; Huang S.-P. | Scientific Reports | 18 | 19 | |
2015 | Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer | CHAO-YUAN HUANG ; Huang S.-P.; Lin V.C.; Yu C.-C.; Chang T.-Y.; Lu T.-L.; Chiang H.-C.; Bao B.-Y. | Scientific Reports | 28 | 23 | |
2014 | Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients | Lin V.C.; CHAO-YUAN HUANG ; Lee Y.-C.; Yu C.-C.; Chang T.-Y.; Lu T.-L.; Huang S.-P.; Bao B.-Y. | Archives of Toxicology | 12 | 11 | |
2016 | Inherited variants in Wnt pathway genes influence outcomes of prostate cancer patients receiving androgen deprivation therapy | Geng J.-H.; Lin V.C.; Yu C.-C.; CHAO-YUAN HUANG ; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Huang S.-P.; Bao B.-Y. | International Journal of Molecular Sciences | 15 | 14 | |
2021 | NRG1 genetic variant influences the efficacy of androgen-deprivation therapy in men with prostate cancer | Huang S.-P.; Chen Y.-T.; Chen L.-C.; Lee C.-H.; CHAO-YUAN HUANG ; Yu C.-C.; Lin V.C.; Lu T.-L.; Bao B.-Y. | Biomedicines | 2 | 3 | |
2011 | Polymorphisms inside MicroRNAs and MicroRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy | Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU ; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Chen L.-M.; Hsieh C.-J.; Huang S.-P. | Clinical Cancer Research | 64 | 56 | |
2016 | Prognostic relevance of methylenetetrahydrofolate reductase polymorphisms for prostate cancer | Lin V.C.; Lu T.-L.; Yin H.-L.; Yang S.-F.; Lee Y.-C.; Liu C.-C.; CHAO-YUAN HUANG ; Yu C.-C.; Chang T.-Y.; Huang S.-P.; Bao B.-Y. | International Journal of Molecular Sciences | 7 | 4 | |
2019 | Prognostic value of CD1B in localised prostate cancer | Lee C.-H.; Chen L.-C.; Yu C.-C.; Lin W.-H.; Lin V.C.; CHAO-YUAN HUANG ; Lu T.-L.; Huang S.-P.; Bao B.-Y. | International Journal of Environmental Research and Public Health | 14 | 11 | |
2016 | Prognostic value of prostaglandin-endoperoxide synthase 2 polymorphisms in prostate cancer recurrence after radical prostatectomy | Lee C.-H.; Pao J.-B.; Lu T.-L.; Lee H.-Z.; Lee Y.-C.; Liu C.-C.; CHAO-YUAN HUANG ; Lin V.C.; Yu C.-C.; Yin H.-L.; Huang S.-P.; Bao B.-Y. | International Journal of Medical Sciences | 5 | 2 | |
2011 | Ribosome inactivating protein B-chain induces osteoclast differentiation from monocyte/macrophage lineage precursor cells | Wang Y.-M.; Lu T.-L.; PING-NING HSU ; Tang C.-H.; Chen J.-H.; Liu K.-C.; Kao J.-T.; Tzen J.T.C.; Wu Y.-Y. | Bone | 9 | 9 | |
2012 | Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy | Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU ; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Chen L.-M.; Ting W.-C.; Hsieh C.-J.; Huang S.-P. | International Journal of Cancer | 21 | 19 |